Seagull Drugs Private Limited
Real estate development and management since 1990.
1990 | Delhi (India) | Merged
Seagull Drugs Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.25 M
- Company Age 35 Year, 1 Month
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 10.30 Cr
- Revenue Growth %
- Profit Growth -65.15%
- Ebitda -68.83%
- Net Worth -24.43%
- Total Assets -17.36%
About Seagull Drugs
Seagull Drugs Private Limited (SDPL) is Amalgamated company established on 15 Mar 1990 with its office registered at Delhi, India and has been running since 35 Year, 1 Month with a paid up capital of 2.25 M. According to MCA records, 2 Directors are linked to this company as of 18 Jan 2025.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24299DL1990PTC039516
- Company No.
039516
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Mar 1990
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Real Estate and Construction
Seagull Drugs Private Limited
Explore comprehensive data for Seagull Drugs Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Seagull Drugs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neelam Oberoi  | Director | 21-Jun-1996 | Current |
| Amir Sehgal | Director | 16-Sep-1996 | Current |
Financial Performance of Seagull Drugs.
Seagull Drugs Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 65.15% decrease in profit. The company's net worth observed a substantial decline by a decrease of 24.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Seagull Drugs?
In 2020, Seagull Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ozone Pharmaceuticals LimitedNeelam Oberoi is a mutual person
Charges (Loans)
Open Charges
₹0
Satisfied Charges
₹103.00 M
Charges Breakdown by Lending Institutions
- Citibank N.A : 10.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Mar 2013 | Citibank N.A | ₹10.30 Cr | Satisfied |
How Many Employees Work at Seagull Drugs?
Unlock and access historical data on people associated with Seagull Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Seagull Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seagull Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Seagull Drugs
Recent activity within the organization
- Annual General Meeting
Seagull Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
- Balance Sheet
Seagull Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Delhi.
- Charges
A charge registered on 11 Mar 2013 via Charge ID 10420181 with Citibank N.A was fully satisfied on 10 Aug 2016.
- Charges
A charge with Citibank N.A amounted to Rs. 103.00 M with Charge ID 10420181 was registered on 11 Mar 2013.
- Director Appointment
Amir Chand Sehgal was appointed as a Director was appointed as a Director on 16 Sep 1996 & has been associated with this company since 28 years 7 months .
- Director Appointment
Neelam Oberoi was appointed as a Director was appointed as a Director on 21 Jun 1996 & has been associated with this company since 28 years 10 months .
Frequently asked questions
What is the Incorporation or founding date of Seagull Drugs Private Limited?
Seagull Drugs Private Limited was incorporated on 15 Mar 1990.
What is authorized share capital and paid-up capital of Seagull Drugs Private Limited?
The authorized share capital of Seagull Drugs Private Limited is ₹ 2.50 M and paid-up capital is ₹ 2.25 M.
Who are the current board members & directors of Seagull Drugs Private Limited?
Currently 2 directors are associated with Seagull Drugs Private Limited.
- Neelam Oberoi
- Amir Chand Sehgal
What is the registered address of Seagull Drugs Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Seagull Drugs Private Limited is A-5, New Krishna Park Vikas Puri India, Newdelhi, Delhi, 110018.
What is the corporate identification number (CIN) and company number of Seagull Drugs Private Limited?
The corporate identification number (CIN) of Seagull Drugs Private Limited is U24299DL1990PTC039516 and the company number is 039516 as per Ministry of Corporate Affairs (MCA).
What change has been observed in the net worth of Seagull Drugs Private Limited, and by what percentage?
The financial reports for the fiscal year 2021 indicates that The net worth of Seagull Drugs Private Limited has experienced an downturn of -24.43%.
When was the last Balance Sheet of Seagull Drugs Private Limited filed with the ROC?
The most recent Balance Sheet for Seagull Drugs Private Limited was filed with the ROC on 31 Mar 2022.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records